hair loss with glp-1 loss: why it happens, what the research shows, and how to protect your hair Turning Hair Loss Awareness Into

Instead of waiting until advanced disease stages or after other therapies fail, GLP-1s are increasingly being used early, sometimes even at diagnosis

Danuglipron is an investigational medicine that is taken as a tablet by mouth and is currently not approved for use by health authorities

(NIDDK) That does not mean they do all the work

In clinical trial protocols, retatrutide followed a structured dose-escalation schedule designed to minimise gastrointestinal side effects the most commonly reported adverse effects with this class of medication

Credit: J

But as frontline clinicians, were left to translate complex approvals and payer requirements into something workable for patients